Bartonellosis Global Market Report 2025

Description

Bartonellosis is a bacterial infection caused by the Bartonella genus, affecting the skin, lymph nodes, and internal organs. Prompt diagnosis and antibiotic treatment are crucial to prevent severe systemic complications and ensure effective disease management.

The primary forms of bartonellosis include cat scratch disease (CSD), trench fever, Bartonella endocarditis, and others. Cat scratch disease, caused by Bartonella henselae and transmitted through cat scratches or bites, results in symptoms such as swollen lymph nodes, fever, and fatigue. Diagnosis involves various methods, including polymerase chain reaction (PCR) testing, serological testing, culture techniques, and histological examination. Treatment options consist of antibiotics, antibacterial agents, and supportive care. The disease is managed by various end-users, including hospitals and clinics, diagnostic laboratories, and others.

The bartonellosis market research report is one of a series of new reports from The Business Research Company that provides bartonellosis market statistics, including the bartonellosis industry global market size, regional shares, competitors with the bartonellosis market share, detailed bartonellosis market segments, market trends, and opportunities, and any further data you may need to thrive in the bartonellosis industry. This bartonellosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bartonellosis market size has grown rapidly in recent years. It will grow from $1.17 billion in 2024 to $1.31 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth during the historic period can be attributed to the rising prevalence of Bartonella disease, increased healthcare expenditure, greater funding for research and development, the growing incidence of transmissible illnesses, and the increasing occurrence of infectious diseases.

The bartonellosis market size is expected to see rapid growth in the next few years. It will grow to $2.03 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth during the forecast period can be attributed to the increasing incidence of zoonotic diseases, rising disease awareness, a growing pet-owning population, a stronger focus on personalized medicine, and greater awareness of cat scratch disease. Key trends expected in this period include advancements in medical technology and biotechnology, the development of combined testing methods, improvements in diagnostic techniques, and continuous research and development efforts.

The increasing prevalence of zoonotic diseases is anticipated to drive the growth of the bartonellosis market in the coming years. Zoonotic diseases are infections transmitted from animals to humans, either directly or via vectors. The surge in zoonotic disease cases can be attributed to factors such as heightened human-animal interactions, environmental changes, deforestation, global travel, and the cross-species spread of pathogens. Bartonellosis serves as a significant example of a bacterial pathogen transmitted through animal vectors such as fleas, ticks, and lice, which can infect humans and cause various clinical manifestations. This underscores the importance of understanding vector-borne disease transmission in public health. For instance, in January 2023, a report published by the Government of Canada, a federal authority, indicated that 159 rabies samples were submitted in November 2022, compared to 135 samples in October 2022. Consequently, the growing incidence of zoonotic diseases is fueling the expansion of the bartonellosis market.

Leading companies in the bartonellosis market are prioritizing fundraising initiatives to enhance early detection and improve treatment options for the disease. These efforts involve organizations raising funds to support research, diagnosis, treatment, and prevention of bartonellosis, thereby fostering innovation and improving access to healthcare solutions. For example, in April 2022, the Global Lyme Alliance (GLA), a US-based nonprofit organization, launched a crowdfunding campaign to raise $300,000 for pioneering research on Bartonella, a hidden pathogen linked to severe health conditions such as neuroinflammation and psychiatric disorders. This initiative coincided with Lyme Disease Awareness Month and aimed to deepen the understanding of Bartonella's behavior within the body, which is essential for developing more effective treatments for Bartonella infections and related conditions such as Lyme disease. The campaign highlighted the need for greater awareness and funding to assist individuals affected by these debilitating diseases.

In October 2024, R.E.D. Laboratories, a Belgium-based biomedical diagnostic company, collaborated with IGeneX Inc. to broaden access to IGeneX's advanced testing panels. Through this partnership, customers in Europe, Africa, and the Middle East can directly access IGeneX's specialized Lyme disease and co-infection tests via RED Labs. IGeneX Inc. is a US-based provider of diagnostic test kits for bartonellosis.

Major players in the bartonellosis market are Mayo Clinic Laboratories, Northwell Health Labs, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., Alberta Precision Laboratories, Jiangsu BioPerfectus Technologies Co. Ltd., ARUP Laboratories, Surmodics Inc., Medical Diagnostic Laboratories LLC, Creative Biolabs, IGeneX Inc., Karius Inc., Synnovis Group LLP, Galaxy Diagnostics Inc., Gold Standard Diagnostics, Eurofins Biomnis, AMMAGENOMICS Private Limited, Ringbio.

North America was the largest region in the bartonellosis market in 2024. The regions covered in bartonellosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bartonellosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bartonellosis market consists of revenues earned by entities by providing services such as medical consultation, symptom management, and vector control and prevention. The market value includes the value of related goods sold by the service provider or included within the service offering. The bartonellosis market includes sales of diagnostic kits, preventive products, pain relievers, and immune support supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bartonellosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bartonellosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bartonellosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bartonellosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Disease Type: Cat Scratch Disease (CSD); Trench Fever; Bartonella Endocarditis; Other Disease Types
2) By Diagnostic Method: Polymerase Chain Reaction (PCR) Testing; Serological Testing; Culture Methods; Histological Testing
3) By Treatment: Antibiotics; Antibacterial Agents; Supportive Care
4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Other End-Users
Subsegments:
1) By Cat Scratch Disease (CSD): Immunocompetent Hosts; Immunocompromised Hosts; Neurological Complications
2) By Trench Fever: Acute Trench Fever; Chronic Trench Fever; Asymptomatic Infections
3) By Bartonella Endocarditis: Native Valve Endocarditis; Prosthetic Valve Endocarditis; Bloodstream Infections
4) By Other Disease Types: Bacillary Angiomatosis; Parinaud's Oculoglandular Syndrome; Bartonella-associated Vasculitis
Companies Mentioned: Mayo Clinic Laboratories; Northwell Health Labs; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; IDEXX Laboratories Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33977

1. Executive Summary

2. Bartonellosis Market Characteristics

3. Bartonellosis Market Trends And Strategies

4. Bartonellosis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Bartonellosis Growth Analysis And Strategic Analysis Framework

5.1. Global Bartonellosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Bartonellosis Market Growth Rate Analysis
5.4. Global Bartonellosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Bartonellosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Bartonellosis Total Addressable Market (TAM)

6. Bartonellosis Market Segmentation

6.1. Global Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cat Scratch Disease (CSD)
Trench Fever
Bartonella Endocarditis
Other Disease Types
6.2. Global Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction (PCR) Testing
Serological Testing
Culture Methods
Histological Testing
6.3. Global Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antibiotics
Antibacterial Agents
Supportive Care
6.4. Global Bartonellosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostic Laboratories
Other End-Users
6.5. Global Bartonellosis Market, Sub-Segmentation Of Cat Scratch Disease (CSD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunocompetent Hosts
Immunocompromised Hosts
Neurological Complications
6.6. Global Bartonellosis Market, Sub-Segmentation Of Trench Fever, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Trench Fever
Chronic Trench Fever
Asymptomatic Infections
6.7. Global Bartonellosis Market, Sub-Segmentation Of Bartonella Endocarditis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Native Valve Endocarditis
Prosthetic Valve Endocarditis
Bloodstream Infections
6.8. Global Bartonellosis Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bacillary Angiomatosis
Parinaud's Oculoglandular Syndrome
Bartonella-associated Vasculitis

7. Bartonellosis Market Regional And Country Analysis

7.1. Global Bartonellosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Bartonellosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bartonellosis Market

8.1. Asia-Pacific Bartonellosis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bartonellosis Market

9.1. China Bartonellosis Market Overview
9.2. China Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bartonellosis Market

10.1. India Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bartonellosis Market

11.1. Japan Bartonellosis Market Overview
11.2. Japan Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bartonellosis Market

12.1. Australia Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bartonellosis Market

13.1. Indonesia Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bartonellosis Market

14.1. South Korea Bartonellosis Market Overview
14.2. South Korea Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bartonellosis Market

15.1. Western Europe Bartonellosis Market Overview
15.2. Western Europe Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bartonellosis Market

16.1. UK Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bartonellosis Market

17.1. Germany Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bartonellosis Market

18.1. France Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bartonellosis Market

19.1. Italy Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bartonellosis Market

20.1. Spain Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bartonellosis Market

21.1. Eastern Europe Bartonellosis Market Overview
21.2. Eastern Europe Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bartonellosis Market

22.1. Russia Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bartonellosis Market

23.1. North America Bartonellosis Market Overview
23.2. North America Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bartonellosis Market

24.1. USA Bartonellosis Market Overview
24.2. USA Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bartonellosis Market

25.1. Canada Bartonellosis Market Overview
25.2. Canada Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bartonellosis Market

26.1. South America Bartonellosis Market Overview
26.2. South America Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bartonellosis Market

27.1. Brazil Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bartonellosis Market

28.1. Middle East Bartonellosis Market Overview
28.2. Middle East Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bartonellosis Market

29.1. Africa Bartonellosis Market Overview
29.2. Africa Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bartonellosis Market Competitive Landscape And Company Profiles

30.1. Bartonellosis Market Competitive Landscape
30.2. Bartonellosis Market Company Profiles
- 30.2.1. Mayo Clinic Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Northwell Health Labs Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. IDEXX Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Bartonellosis Market Other Major And Innovative Companies

31.1. Bio-Rad Laboratories Inc.
31.2. Alberta Precision Laboratories
31.3. Jiangsu BioPerfectus Technologies Co. Ltd.
31.4. ARUP Laboratories
31.5. Surmodics Inc.
31.6. Medical Diagnostic Laboratories LLC
31.7. Creative Biolabs
31.8. IGeneX Inc.
31.9. Karius Inc.
31.10. Synnovis Group LLP
31.11. Galaxy Diagnostics Inc.
31.12. Gold Standard Diagnostics
31.13. Eurofins Biomnis
31.14. AMMAGENOMICS Private Limited
31.15. Ringbio

32. Global Bartonellosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bartonellosis Market

34. Recent Developments In The Bartonellosis Market

35. Bartonellosis Market High Potential Countries, Segments and Strategies

35.1 Bartonellosis Market In 2029 - Countries Offering Most New Opportunities
35.2 Bartonellosis Market In 2029 - Segments Offering Most New Opportunities
35.3 Bartonellosis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer